Results 61 to 70 of about 485 (123)

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy. [PDF]

CMAJ
Schellenberg KL, Caspar-Bell G, Ellis C, Johnston W, King A, King M, Korngut L, Kushneriuk B, Lavoie AJ, McGonigle R, Newton J, O'Connell C, Shoesmith C, Suchowersky O, Warman-Chardon J, Wunder S, Pfeffer G.   +16 more
europepmc   +1 more source

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. [PDF]

Neurotherapeutics
Sangotra A, Reddy SL, Kuo CJ, Xiang W, Merry DE, Grunseich C, Wang S, Lieberman AP.   +7 more
europepmc   +1 more source

Neuromuscular junction pathology is correlated with differential motor unit vulnerability in spinal and bulbar muscular atrophy. [PDF]

Acta Neuropathol Commun, 2022
Molotsky E, Liu Y, Lieberman AP, Merry DE.   +3 more
europepmc   +1 more source

Análisis genético y molecular de las enfermedades neurológicas hereditarias [PDF]

, 1996
Palau, Francesc
core  

One case of spinal bulbar muscular atrophy misdiagnosed as polymyositis: Case report. [PDF]

Medicine (Baltimore)
Mu YS, Yao JY, Li F.
europepmc   +1 more source

Hearing Function in Spinal and Bulbar Muscular Atrophy (SBMA): A Case Control Study From a Tertiary Referral Center. [PDF]

Eur J Neurol
Blasi L, Franz L, Romito A, Fortuna A, Minicuci GM, Bebeti A, Paredi F, Ragona RM, Pennuto M, de Filippis C, Marioni G, Sorarù G.   +11 more
europepmc   +1 more source

More than autophony: a case of Kennedy's disease presenting with autophony as an early clinical manifestation. [PDF]

J Laryngol Otol
Lee HS, Choi J, Kwon DY.
europepmc   +1 more source

Higher than expected incident cases of spinal bulbar muscular atrophy in western Canada. [PDF]

Brain
Lamont R, King M, King A, Schellenberg K, Pfeffer G.   +4 more
europepmc   +1 more source

A spinal and bulbar muscular atrophy (SBMA) disease-specific human embryonic stem cell (hESC) line, UMICHe002-A/UM197-1. [PDF]

Stem Cell Res
Erliandri I, Sangotra A, Keller L, Lieberman AP, Smith GD.   +4 more
europepmc   +1 more source

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. [PDF]

Nat Commun, 2023
Prakasam R, Bonadiman A, Andreotti R, Zuccaro E, Dalfovo D, Marchioretti C, Tripathy D, Petris G, Anderson EN, Migazzi A, Tosatto L, Cereseto A, Battaglioli E, Sorarù G, Lim WF, Rinaldi C, Sambataro F, Pourshafie N, Grunseich C, Romanel A, Pandey UB, Contestabile A, Ronzitti G, Basso M, Pennuto M.   +24 more
europepmc   +1 more source